Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA’s New Approach Methodologies Framework Rests On Four Validation Pillars
Mar 18 2026
•
By
Sue Sutter
The FDA is encouraging drug developers to explore alternatives to animal testing.
(Source: Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Approval Standards
More from United States